PROGERIA

Clinical trials for PROGERIA explained in plain language.

Never miss a new study

Get alerted when new PROGERIA trials appear

Sign up with your email to follow new studies for PROGERIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to slow rapid aging in kids

Disease control ENROLLING_BY_INVITATION

This study tests adding everolimus to the standard drug lonafarnib for children with progeria, a rare condition that causes rapid aging. The goal is to find the safest dose and see if the combination improves weight gain and blood vessel health. About 80 participants will take pa…

Matched conditions: PROGERIA

Phase: PHASE1, PHASE2 • Sponsor: Boston Children's Hospital • Aim: Disease control

Last updated May 14, 2026 12:03 UTC

PROGERIA

Get alerted when new PROGERIA trials appear

New drug combo aims to slow rapid aging in kids